Nick Schifrin is PBS NewsHour’s Foreign Affairs and Defense Correspondent. He leads NewsHour’s daily foreign coverage, including multiple trips to Ukraine since the full-scale invasion, and ...
Madrigal said that all patients enrolled in MAESTRO-NASH - which include up to 2,000 in total - are continuing on therapy after the initial 52-week treatment period.
Infinity Pharmaceuticals Inc. 0.00% $90.76 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback